B. Braun Melsungen AG, the parent company of B. Braun Medical Oy operating in Finland, is one of the largest private companies and the leading healthcare company in the world. The company manufactures and markets medicines and supplies for anaesthesia and intensive care. The company’s products also include surgical supplies, dialysis equipment and supplies, and outpatient products. B. Braun Medical Oy in Finland is one of the Group’s oldest subsidiaries.
For more than 40 years, B. Braun has been actively involved in stoma care research, providing its users and medical staff with innovative solutions through its wide range of dressings and accessories. B. Braun’s stoma care research aims to develop products that improve users’ quality of life. It is important that the products guarantee the user discreetness, a sense of comfort, security and ease of use.
Cancer Society of Finland
The Cancer Society of Finland consists of 12 regional cancer societies and six national patient organisations. The CSF maintains the Finnish Cancer Registry. Cancer Foundation Finland is a charitable organisation and the main private funder of cancer research in the country.
The strategy of the Cancer Society and the Cancer Foundation Finland is their pledge to act decisively to promote health, prevent cancer, support people with cancer and reduce the adverse effects of cancer throughout the country.
Colores is a member association of Cancer Society of Finland.
Cardirad Oy markets and distributes healthcare products and medicine in the Nordic and Baltic countries from the leading vendors of the world. Our primary focus is on invasive cardiology, radiology, and nuclear medicine.
We market SIRT (also known as radio-embolisation), which is a special type of internal radiotherapy that targets liver tumours inside the body with high doses of radiation. It involves injecting millions of tiny radioactive ‘beads’ called microspheres into the main blood vessel of the liver through a long thin tube (catheter). SIRT is used to treat liver tumours that cannot be removed by surgery. The two commonest uses of SIRT are to treat liver tumours that have spread from the bowel and primary liver cancer
Coloplast develops products and services that make life easier for people with very personal and private medical conditions.
Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.
Our business includes Ostomy Care, Continence Care, Wound & Skin Care and Interventional Urology. We operate globally and our organisation is about 12,000 people strong.
Dansac develops, manufactures and markets unique stoma care products that solve specific problems and improve quality of life for people with a stoma – and for people who work with stoma care. This is our mission!
Dansac focuses solely on stoma care, nothing else. We consider each stoma to be an individual case that requires unique care and products. We do not hesitate to find new ways and to think differently.
Hollister Incorporated is an independent, employee-owned company that develops, manufactures, and markets healthcare products and services worldwide.
We offer advanced medical products for Ostomy Care, which includes two strong global brands – Hollister Ostomy and Dansac Ostomy; Continence Care; Critical Care; and Wound Care. We also provide innovative healthcare programs and services, as well as educational materials for patients and healthcare professionals.
Digestive Cancers Europe
Digestive Cancers Europe DiCE is the voice of digestive cancer patients in Europe. Its aim is to save lives by bringing together all key stakeholders in the fight against these cancers. We are campaigning for the adoption of best practices in prevention, diagnosis, treatment and follow up.
Colores is a full member of DiCE.
Docrates Cancer Center
Docrates Cancer Center is a Finnish-owned, international hospital in Helsinki specialising in cancer treatment. We provide individual services for cancer patients throughout the treatment chain, from diagnostics to post-treatment follow-up. After diagnosis and imaging, treatment can be planned and initiated without delay. Our unique concept attracts patients from all over the world. We have treated patients from more than 60 different countries. Together with our network of leading clinical experts, we provide genuinely individual state-of-the-art cancer treatment services.
Read more about our article: Colorectal cancer is the common name for colon cancer and rectal cancer
One step ahead www.docrates.com
Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, and consumer health and animal products. We aspire to being the best healthcare company in the world, and are dedicated to providing leading innovations and solutions for tomorrow. We have made it our mission to provide innovative, distinctive products and services that save and improve lives and satisfy customer needs.
Nordic Drugs – A Nordic Pharmaceutical Company
Nordic Drugs AB is a Nordic pharmaceutical company that was established in 1995. We are headquartered in Malmö, where some of our products are manufactured, and we have sales organizations in Denmark, Finland, Norway, and Iceland. Our company offers a range of highly specialized, proprietary, and licensed products in oncology, rheumatology, pain, addiction care, hematology, women’s health, and gastroenterology.
Over the almost 30 years that Nordic Drugs has been in existence, our company has grown and developed into a stable and well-known supplier in the Nordic pharmaceutical market, characterized by high delivery reliability and well-known, strong brands in both Rx and OTC.
Good health is vital to all of us; as are sustainable solutions to the most pressing healthcare challenges we are facing globally. We at Pfizer are committed to applying science and our global resources to develop breakthroughs that change patients’ lives, to improve health and well-being at every stage of life. Our goal is to ensure that people have the opportunity to lead healthier lives with access to effective and innovative treatments when they need them. We aim to bring hope to patients and their loved ones in the midst of illness.
Breakthroughs that change patients’ lives.
Pierre Fabre Pharma Norden
Standing with patients in the fight against cancer.
Pierre Fabre Group is a global company based in France and employing 10,400 people worldwide. To safeguard our independence and long-term focus, as our founder Pierre Fabre intended, a majority stake in the company is held by a not-for-profit foundation.
At Pierre Fabre, we care for the person as a whole. Our products are used to treat various cancers and to alleviate sensitive skin and dermatological side effects that may occur after long-term treatment.
The purpose of our cancer research is to improve the care of patients whose treatment needs are currently going unmet as a result of their condition. We are guided at all times by our core values and the goal of improving individual wellbeing.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Servier is an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Since opening our first laboratory in 1954, we have been committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to provide future generations with a world where quality healthcare is available and accessible to all.
We are a leading force in cardiology—number 2 in Europe, number 5 worldwide—and oncology has become a top priority in recent years; we also manufacture high-quality generic drugs.
The Funding Centre for Social Welfare and Health Organisations (STEA) manages the funding granted for projects which are non-profit by nature and promote health and wellbeing, from the gaming revenue of Veikkaus Oy.
The funding granted from Veikkaus Oy’s revenue for projects related to arts, culture, and sports are managed by the Ministry of Education and Culture, and funding for projects related to the promotion of horse breeding and equestrian sports by the Ministry of Agriculture and Forestry.